.png)
Introduction: What Are Neonatal Infants Enteral Feeding Devices?
Neonatal infants enteral feeding devices are specialized medical tools designed to provide nutrition directly to the gastrointestinal tract of newborns who cannot eat orally. These devices play a critical role in neonatal intensive care units (NICUs), helping preterm or critically ill infants receive essential nutrients for survival and growth. Enteral feeding is preferred over parenteral feeding as it promotes gastrointestinal function and reduces the risk of infections.
Neonatal Infants Enteral Feeding Devices Market was valued at USD 363.3 million in 2023 and is projected to grow to USD 382.92 million by 2024. It is further anticipated to reach USD 583.22 million by 2032, registering a compound annual growth rate (CAGR) of 5.4% during the forecast period from 2024 to 2032.
Market Overview: USA's Growing Neonatal Infants Enteral Feeding Devices Market
The USA has emerged as a dominant market for neonatal infants enteral feeding devices due to the increasing prevalence of preterm births, advancements in neonatal care, and rising awareness about enteral feeding benefits. Supported by government initiatives and a well-established healthcare infrastructure, the market in the USA is projected to grow significantly, with a focus on innovation and improved patient outcomes.
Global Growth Insights unveils the top List Global Neonatal Infants Enteral Feeding Devices Companies:
Moog Medical Devices
- Headquarters: New York, USA
- Revenue (2022): USD 3.2 billion
- Overview: Moog Medical Devices is renowned for its advanced enteral feeding pumps and related systems. The company’s devices are widely used in NICUs globally, offering precision and reliability for neonatal care.
Halyard Health
- Headquarters: Alpharetta, Georgia, USA
- Revenue (2022): USD 1.63 billion
- Overview: Halyard Health provides innovative enteral feeding devices tailored for neonatal patients. Their product portfolio emphasizes safety, reducing the risk of complications associated with feeding.
Angel Canada Enterprises
- Headquarters: Ontario, Canada
- Revenue (2022): CAD 25 million
- Overview: Specializing in enteral feeding accessories, Angel Canada Enterprises serves the North American market with cost-effective and high-quality solutions for neonatal care.
ConMed Corporation
- Headquarters: Utica, New York, USA
- Revenue (2022): USD 1.08 billion
- Overview: ConMed Corporation offers a range of enteral feeding devices, including feeding tubes and syringes, designed to meet the specific needs of neonatal patients in critical care settings.
Degania Silicone
- Headquarters: Israel
- Revenue (2022): USD 150 million
- Overview: Degania Silicone specializes in silicone-based enteral feeding devices, known for their durability and patient comfort. Their neonatal products are widely used in Europe and Asia.
Corpak Medical Systems
- Headquarters: Illinois, USA
- Revenue (2022): USD 220 million
- Overview: Corpak Medical Systems provides innovative neonatal feeding solutions that prioritize safety and ease of use, making them a trusted partner in NICUs.
Boston Scientific
- Headquarters: Marlborough, Massachusetts, USA
- Revenue (2022): USD 12.68 billion
- Overview: Boston Scientific leverages its expertise in medical device technology to produce advanced enteral feeding systems, focusing on improving the quality of neonatal care.
Abbott Laboratories
- Headquarters: Abbott Park, Illinois, USA
- Revenue (2022): USD 43.65 billion
- Overview: Abbott Laboratories is a market leader in nutritional products and enteral feeding devices, offering comprehensive solutions for neonatal feeding challenges.
Asept Inmed
- Headquarters: France
- Revenue (2022): EUR 75 million
- Overview: Asept Inmed manufactures a wide range of enteral feeding devices and accessories, catering to the specific requirements of neonatal care providers.
Applied Medical Technology
- Headquarters: Ohio, USA
- Revenue (2022): USD 50 million
- Overview: Known for its innovative enteral feeding solutions, Applied Medical Technology focuses on creating devices that ensure safety and comfort for neonatal patients.
Additional Notable Companies
Fresenius
- Headquarters: Bad Homburg, Germany
- Revenue (2022): EUR 37.18 billion
- Overview: Fresenius provides enteral nutrition and feeding devices that are trusted by healthcare providers worldwide.
Cook Medical
- Headquarters: Bloomington, Indiana, USA
- Revenue (2022): USD 2 billion
- Overview: Cook Medical’s neonatal feeding devices are engineered to provide optimal nutrition delivery with minimal risk.
Alcor Scientific
- Headquarters: Rhode Island, USA
- Revenue (2022): USD 40 million
- Overview: Alcor Scientific offers precision feeding devices and solutions tailored for neonatal care settings.
Medtronic (Covidien)
- Headquarters: Dublin, Ireland
- Revenue (2022): USD 31.68 billion
- Overview: Medtronic (Covidien) is a global leader in healthcare technology, producing advanced neonatal enteral feeding devices.
BARD Access Systems
- Headquarters: Salt Lake City, Utah, USA
- Revenue (2022): USD 2 billion
- Overview: BARD Access Systems provides enteral feeding solutions designed to meet the unique needs of neonatal patients.
Recent Developments in the Neonatal Infants Enteral Feeding Devices Market
The market has seen significant advancements, including:
- Improved safety features: Reducing risks of aspiration and contamination.
- Technological innovation: AI-driven devices for precise feeding and monitoring.
- Increased focus on sustainability: Eco-friendly materials in device manufacturing.
Conclusion: Market Outlook
The Neonatal Infants Enteral Feeding Devices market is on a steady growth trajectory, driven by technological advancements and the increasing demand for precision neonatal care. With leading companies like Abbott Laboratories, Boston Scientific, and Medtronic driving innovation, the market is well-positioned to address the growing needs of healthcare providers and neonatal patients. The USA remains a key contributor, thanks to its robust healthcare infrastructure and focus on research and development.